KURLAND FRED 4
4 · Aridis Pharmaceuticals, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2018-12-05+17,000→ 40,024 totalExercise: $8.50Exp: 2028-12-05→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option vest as follows: in equal annual installments over the 48 months following the date of grant.